| Wassim Mazraany, MD | |
|
275 Varnum Ave Ste 203, Lowell, MA 01854-2109 | |
| (978) 458-4300 | |
| (978) 458-4311 |
| Full Name | Wassim Mazraany |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 29 Years |
| Location | 275 Varnum Ave Ste 203, Lowell, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700952314 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 016008 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lowell General Hospital | Lowell, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lowell Community Health Center Inc | 6204807944 | 65 |
| Riverside Surgical Associates, Pc | 8123263837 | 6 |
News Archive
While Health officials in Indonesia are still trying to track down the source of infection in a cluster of six deaths in one family from H5N1 bird flu, tests show that two more people have also died of the same disease.
To improve communication about pain between patients and physicians, a team led by researchers from the University of Pittsburgh and UPMC has developed a mobile application called "Painimation" that has the potential to assess and monitor pain better than any previously used measurement tools.
Lumenis Ltd., the world's largest medical laser company, announced today they will be focusing their attention at this year's AAO-HNS annual meeting in San Diego, California, on an educational event to discuss different treatment options for laryngeal cancer.
Accountable Care Organizations, a key feature of the Affordable Care Act, aim to control health care costs, enhance quality in health care and improve population health. But what does "improving population health" really mean? This is the question asked in a new viewpoint article by Weill Cornell Medical College researchers published in the March 20 issue of the Journal of the American Medical Association.
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
› Verified 4 days ago
| Entity Name | Lowell Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952307530 PECOS PAC ID: 6204807944 Enrollment ID: O20040804001749 |
News Archive
While Health officials in Indonesia are still trying to track down the source of infection in a cluster of six deaths in one family from H5N1 bird flu, tests show that two more people have also died of the same disease.
To improve communication about pain between patients and physicians, a team led by researchers from the University of Pittsburgh and UPMC has developed a mobile application called "Painimation" that has the potential to assess and monitor pain better than any previously used measurement tools.
Lumenis Ltd., the world's largest medical laser company, announced today they will be focusing their attention at this year's AAO-HNS annual meeting in San Diego, California, on an educational event to discuss different treatment options for laryngeal cancer.
Accountable Care Organizations, a key feature of the Affordable Care Act, aim to control health care costs, enhance quality in health care and improve population health. But what does "improving population health" really mean? This is the question asked in a new viewpoint article by Weill Cornell Medical College researchers published in the March 20 issue of the Journal of the American Medical Association.
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
› Verified 4 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
While Health officials in Indonesia are still trying to track down the source of infection in a cluster of six deaths in one family from H5N1 bird flu, tests show that two more people have also died of the same disease.
To improve communication about pain between patients and physicians, a team led by researchers from the University of Pittsburgh and UPMC has developed a mobile application called "Painimation" that has the potential to assess and monitor pain better than any previously used measurement tools.
Lumenis Ltd., the world's largest medical laser company, announced today they will be focusing their attention at this year's AAO-HNS annual meeting in San Diego, California, on an educational event to discuss different treatment options for laryngeal cancer.
Accountable Care Organizations, a key feature of the Affordable Care Act, aim to control health care costs, enhance quality in health care and improve population health. But what does "improving population health" really mean? This is the question asked in a new viewpoint article by Weill Cornell Medical College researchers published in the March 20 issue of the Journal of the American Medical Association.
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
› Verified 4 days ago
| Entity Name | Riverside Surgical Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538405378 PECOS PAC ID: 8123263837 Enrollment ID: O20130401000159 |
News Archive
While Health officials in Indonesia are still trying to track down the source of infection in a cluster of six deaths in one family from H5N1 bird flu, tests show that two more people have also died of the same disease.
To improve communication about pain between patients and physicians, a team led by researchers from the University of Pittsburgh and UPMC has developed a mobile application called "Painimation" that has the potential to assess and monitor pain better than any previously used measurement tools.
Lumenis Ltd., the world's largest medical laser company, announced today they will be focusing their attention at this year's AAO-HNS annual meeting in San Diego, California, on an educational event to discuss different treatment options for laryngeal cancer.
Accountable Care Organizations, a key feature of the Affordable Care Act, aim to control health care costs, enhance quality in health care and improve population health. But what does "improving population health" really mean? This is the question asked in a new viewpoint article by Weill Cornell Medical College researchers published in the March 20 issue of the Journal of the American Medical Association.
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wassim Mazraany, MD 275 Varnum Ave Ste 203, Lowell, MA 01854-2109 Ph: (978) 458-4300 | Wassim Mazraany, MD 275 Varnum Ave Ste 203, Lowell, MA 01854-2109 Ph: (978) 458-4300 |
News Archive
While Health officials in Indonesia are still trying to track down the source of infection in a cluster of six deaths in one family from H5N1 bird flu, tests show that two more people have also died of the same disease.
To improve communication about pain between patients and physicians, a team led by researchers from the University of Pittsburgh and UPMC has developed a mobile application called "Painimation" that has the potential to assess and monitor pain better than any previously used measurement tools.
Lumenis Ltd., the world's largest medical laser company, announced today they will be focusing their attention at this year's AAO-HNS annual meeting in San Diego, California, on an educational event to discuss different treatment options for laryngeal cancer.
Accountable Care Organizations, a key feature of the Affordable Care Act, aim to control health care costs, enhance quality in health care and improve population health. But what does "improving population health" really mean? This is the question asked in a new viewpoint article by Weill Cornell Medical College researchers published in the March 20 issue of the Journal of the American Medical Association.
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
› Verified 4 days ago
Jehangir Badar, MD Surgery Medicare: Medicare Enrolled Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6439 | |
Suman Bhushan Koganti, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 275 Varnum Ave Ste 203, Lowell, MA 01854 Phone: 978-458-4300 | |
Richard J Rohrer, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 275 Varnum Ave Ste 203, Lowell, MA 01854 Phone: 978-458-4300 Fax: 978-458-4311 | |
Lerna Ozcan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 275 Varnum Ave Ste 203, Lowell, MA 01854 Phone: 978-458-4300 Fax: 978-458-4311 | |
Jana Simonds, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 275 Varnum Ave Ste 203, Lowell, MA 01854 Phone: 978-458-4300 | |
Dr. Michael E Jiser, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 275 Varnum Ave Ste 203, Lowell, MA 01854 Phone: 978-458-4300 Fax: 978-458-4311 |